Leptin: A pivotal mediator of intestinal inflammation in mice

Gastroenterology

Volumn 122, Issue 7, 2002, Pages 2011-2025

  Britta, Siegmund ^a   Hans Anton, Lehr ^b   Giamila, Fantuzzi ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE; CYCLOOXYGENASE 2; DEXTRAN SULFATE; GAMMA INTERFERON; LEPTIN; TRANSCRIPTION FACTOR; TRINITROBENZENESULFONIC ACID;

APOPTOSIS; ARTICLE; COLITIS; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DISEASE SEVERITY; ENTERITIS; ENZYME INDUCTION; KNOCKOUT MOUSE; LAMINA PROPRIA; LYMPHOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0036080142     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.33631     Document Type: Article

References (65)

1. Leptin in the regulation of immunity, inflammation, and hematopoiesis
2. Cell-mediated immunity in genetically obese (C57BL/6J ob/ob) mice
3. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice
4. Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects
5. Impairment of cell-mediated immunity in mutation diabetic mice (db/db)
6. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
7. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors
8. Crystal structure of the obese protein leptin-E100
9. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis
10. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease
11. Leptin is a growth factor for colonic epithelial cells
12. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation in intestinal inflammation
13. Interleukin 18 is a potent proliferative factor for intestinal mucosalymphocytes in Crohn's disease
14. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine
15. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)
16. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease
17. IL-18 a novel immunoregulatory cytokine is up-regulated in Crohn's disease: Expression and localization in intestinal mucosal cells
18. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease
19. Regulation of T-cell apoptosis in inflammatory bowel disease: To die or not to die, that is the mucosal question
20. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production
21. Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice
22. Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results and safety
23. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines
24. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses
25. Antibodies to interleukin 12 abrogate established experimental colitis in mice
26. Adenosine kinase inhibitor GP515 improves experimental colitis in mice
27. Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis
28. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo
29. Assessment of myeloperoxidase activity in whole rat kidney
30. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure
31. Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7)
32. Physiological and cytokine responses in IL-1 beta-deficient mice after zymosan-induced inflammation
33. Interleukin (IL)-12-induced interferon-γ is dependent on caspase-1 processing of the IL-18 precursor
34. Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity
35. Divergent signaling capacities of the long and short isoforms of the leptin receptor
36. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: Role of tumor necrosis factor α and IL-18
37. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
38. Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice
39. Leptin activation of Stat3 in the hypothalamus of wild type and ob/ob mice but not db/db mice
40. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
41. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen
42. Phenotypic abnormalities in macrophages from leptin-deficient, obese mice
43. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis
44. Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males
45. In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)- deficient mice induce intestinal inflammation in immunodeficient hosts
46. Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice
47. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis
48. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice
49. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family
50. Human leptin enhances activation and proliferation of human circulating T lymphocytes
51. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
52. Control of experimental inflammatory bowel disease by regulatory T cells
53. Anti-inflammatory effect of interleukin-10 in rabbit immune complex-induced colitis
54. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
55. Interleukin-10-deficient mice develop chronic enterocolitis
56. Characterisation of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency
57. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: Lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine
58. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice
59. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin
60. Activated immunocompetent cells in rat colitis mucosa induced by dextran sulfate sodium and not complete but partial suppression of colitis by FK506
61. Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice
62. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor
63. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice
64. IL-6 is required for the development of Th1 cell-mediated murine colitis
65. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3